Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism BCL6 inhibitors(B-cell lymphoma 6 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | RU | 01 Jan 2017 |